Literature DB >> 24166093

The EuroNet paediatric hodgkin network - modern imaging data management for real time central review in multicentre trials.

L Kurch1, C Mauz-Körholz, S Bertling, M Wallinder, M Kaminska, D Marwede, L Tchavdarova, T W Georgi, A Elsner, A Barthel, D Stoevesandt, D Hasenclever, B Sattler, O Sabri, D Körholz, R Kluge.   

Abstract

Since 2007, children and adolescents with Hodgkin lymphomas are treated in the Europe-wide EuroNet-PHL trials. A real time central review process for stratification of the patients enhances quality control and efficient therapy management. This process includes reading of all cross-sectional-images. Since reference evaluation is time critical, a fast, easy to handle and safe data transfer is important. In addition, immediate and constant access to all the data has to be guaranteed in case of queries and for regulatory reasons. To meet the mentioned requirements the EuroNet Paediatric Hodgkin Data Network (funded by the European Union - Project Number: 2007108) was established between 2008 and 2011. A respective tailored data protection plan was formulated. The aim of this article is to describe the networks' mode of operation and the advantages for multi-centre trials that include centralized image review. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2013        PMID: 24166093     DOI: 10.1055/s-0033-1354416

Source DB:  PubMed          Journal:  Klin Padiatr        ISSN: 0300-8630            Impact factor:   1.349


  7 in total

1.  Impact of rs12917 MGMT Polymorphism on [18F]FDG-PET Response in Pediatric Hodgkin Lymphoma (PHL).

Authors:  Stefanie Kewitz-Hempel; Lars Kurch; Michaela Cepelova; Ines Volkmer; Axel Sauerbrey; Elke Conrad; Stephanie Knirsch; Gabriele Pöpperl; Daniel Steinbach; Ambros J Beer; Christof M Kramm; Carsten-Oliver Sahlmann; Bernhard Erdlenbruch; Wolf-Dieter Reinbold; Andreas Odparlik; Osama Sabri; Regine Kluge; Martin S Staege
Journal:  Mol Imaging Biol       Date:  2019-12       Impact factor: 3.488

2.  qPET - a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma.

Authors:  Dirk Hasenclever; Lars Kurch; Christine Mauz-Körholz; Andreas Elsner; Thomas Georgi; Hamish Wallace; Judith Landman-Parker; Angelina Moryl-Bujakowska; Michaela Cepelová; Jonas Karlén; Ana Álvarez Fernández-Teijeiro; Andishe Attarbaschi; Alexander Fosså; Jane Pears; Andrea Hraskova; Eva Bergsträsser; Auke Beishuizen; Anne Uyttebroeck; Eckhard Schomerus; Osama Sabri; Dieter Körholz; Regine Kluge
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-03-07       Impact factor: 9.236

3.  Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's Lymphoma.

Authors:  Regine Kluge; Lidia Chavdarova; Martha Hoffmann; Carsten Kobe; Bogdan Malkowski; Françoise Montravers; Lars Kurch; Thomas Georgi; Markus Dietlein; W Hamish Wallace; Jonas Karlen; Ana Fernández-Teijeiro; Michaela Cepelova; Lorrain Wilson; Eva Bergstraesser; Osama Sabri; Christine Mauz-Körholz; Dieter Körholz; Dirk Hasenclever
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

Review 4.  FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas.

Authors:  Sally F Barrington; Regine Kluge
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-04-14       Impact factor: 9.236

5.  Whole-body MRI versus an FDG-PET/CT-based reference standard for staging of paediatric Hodgkin lymphoma: a prospective multicentre study.

Authors:  Suzanne Spijkers; Annemieke S Littooij; Thomas C Kwee; Nelleke Tolboom; Auke Beishuizen; Marrie C A Bruin; Sjoerd G Elias; Tim van de Brug; Goya Enríquez; Constantino Sábado; Elka Miller; Claudio Granata; Charlotte de Lange; Federico Verzegnassi; Mary-Louise C Greer; Bart de Keizer; Rutger A J Nievelstein
Journal:  Eur Radiol       Date:  2020-09-03       Impact factor: 5.315

6.  Automatic classification of lymphoma lesions in FDG-PET-Differentiation between tumor and non-tumor uptake.

Authors:  Thomas W Georgi; Axel Zieschank; Kevin Kornrumpf; Lars Kurch; Osama Sabri; Dieter Körholz; Christine Mauz-Körholz; Regine Kluge; Stefan Posch
Journal:  PLoS One       Date:  2022-04-18       Impact factor: 3.240

7.  Whole-body MRI versus an [18F]FDG-PET/CT-based reference standard for early response assessment and restaging of paediatric Hodgkin's lymphoma: a prospective multicentre study.

Authors:  Suzanne Spijkers; Annemieke S Littooij; Thomas C Kwee; Nelleke Tolboom; Auke Beishuizen; Marrie C A Bruin; Goya Enríquez; Constantino Sábado; Elka Miller; Claudio Granata; Charlotte de Lange; Federico Verzegnassi; Bart de Keizer; Rutger A J Nievelstein
Journal:  Eur Radiol       Date:  2021-05-22       Impact factor: 5.315

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.